Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal
- PMID: 15738532
- DOI: 10.1200/JCO.2005.11.932
Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal
Comment on
-
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.J Clin Oncol. 2005 May 1;23(13):2971-9. doi: 10.1200/JCO.2005.04.021. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738539 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources